Evidence map›Paper›PMID 42522682›Full record

ArticleMicrobial genomics2026

Novel transposon Tn

Michael B Hall, Yiyang Xue, Tricia S E Lee, Ella Herring, Jocelyn Hume, Ryan R Wick, Timothy Kidd, Naomi Runnegar, Patrick N A Harris, Bianca Graves and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbial genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Michael B HallFrazer Institute, The University of Queensland, Herston, QLD 4029, Australia.
Yiyang XueFrazer Institute, The University of Queensland, Herston, QLD 4029, Australia.
Tricia S E LeeFrazer Institute, The University of Queensland, Herston, QLD 4029, Australia.
Ella HerringFrazer Institute, The University of Queensland, Herston, QLD 4029, Australia.
Jocelyn HumeFrazer Institute, The University of Queensland, Herston, QLD 4029, Australia.
Ryan R WickDepartment of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Timothy KiddCentral Microbiology, Pathology Queensland, Royal Brisbane and Women's Hospital, Herston, QLD 4029, Australia.
Naomi RunnegarInfection Management Services, Princess Alexandra Hospital, Brisbane, QLD, Australia.
Patrick N A HarrisFrazer Institute, The University of Queensland, Herston, QLD 4029, Australia.
Bianca GravesCentral Microbiology, Pathology Queensland, Royal Brisbane and Women's Hospital, Herston, QLD 4029, Australia.
Leah W RobertsFrazer Institute, The University of Queensland, Herston, QLD 4029, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Linezolid is a critical last-resort antimicrobial for multidrug-resistant

Indexed as

Anti-Bacterial AgentsDNA Transposable ElementsDrug Resistance, BacterialEnterococcus faeciumGram-Positive Bacterial InfectionsLinezolidPlasmidsDrug Resistance, Multiple, BacterialExtrachromosomal DNAHumansQueenslandAnti-Bacterial AgentsDNA Transposable ElementsExtrachromosomal DNALinezolidEnterococcus faeciumgenomic epidemiologylinear plasmidlinezolid resistancemobile genetic elementstransposon

Identifiers

PMID42522682
PMCPMC13417996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.